Report cover image

Biopharmaceutical Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report By Services (Transportation, Inventory Management, Warehousing & Storage, Packaging Solutions), By Temperature Range, By Region, And Segment Forecasts, 2025 - 2

Publisher Grand View Research
Published Oct 07, 2025
Length 150 Pages
SKU # GV20574996

Description

Biopharmaceutical Cold Chain Third Party Logistics Market Summary

The global biopharmaceutical cold chain third party logistics market size was estimated at USD 30.59 billion in 2024 and is projected to reach USD 74.46 billion by 2033, growing at a CAGR of 10.54% from 2025 to 2033. This market growth is due to the rising demand for temperature-sensitive pharmaceuticals, stringent drug storage and transportation regulatory requirements, and the global expansion of biologics and vaccine distribution.

In addition, increasing outsourcing of logistics services by pharmaceutical companies is further driving market expansion. Furthermore, increasing demand for biologics, vaccines, and temperature-sensitive drugs has significantly expanded the need for reliable cold chain logistics solutions. Biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, require stringent temperature control, typically between 2°C and 8°C, with some requiring ultra-low storage at -70°C or lower-to maintain their efficacy.

Moreover, the growing trend towards personalized medicine has further boosted the need for specialized logistics solutions to ensure product integrity throughout the supply chain.

Global Biopharmaceutical Cold Chain Third Party Logistics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global biopharmaceutical cold chain third party logistics market based on service, temperature range, and region:
  • Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Transportation
  • Air Freight
  • Sea Freight
  • Overland
  • Warehousing & Storage
  • Packaging Solutions
  • Monitoring & Visibility Solutions
  • Inventory Management
  • Others
  • Temperature Range Outlook (Revenue, USD Million, 2021 - 2033)
  • Frozen
  • Ultra-frozen/Deep-Frozen
  • Cryogenic
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Analysis
1.3.1. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Technological Landscape
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
4.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
4.4. Transportation
4.4.1. Transportation market estimates and forecasts 2021 - 2033 (USD Million)
4.4.2. Air Freight
4.4.2.1. Air Freight market estimates and forecasts 2021 - 2033 (USD Million)
4.4.3. Sea Freight
4.4.3.1. Sea Freight market estimates and forecasts 2021 - 2033 (USD Million)
4.4.4. Overland
4.4.4.1. Overland market estimates and forecasts 2021 - 2033 (USD Million)
4.5. Warehousing & Storage
4.5.1. Warehousing & Storage market estimates and forecasts 2021 - 2033 (USD Million)
4.6. Packaging Solutions
4.6.1. Packaging Solutions market estimates and forecasts 2021 - 2033 (USD Million)
4.7. Monitoring & Visibility Solutions
4.7.1. Monitoring & Visibility Solutions market estimates and forecasts 2021 - 2033 (USD Million)
4.8. Inventory Management
4.8.1. Inventory Management market estimates and forecasts 2021 - 2033 (USD Million)
4.9. Others
4.9.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 5. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Movement Analysis
5.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Temperature Range, 2021 to 2033 (USD Million)
5.4. Frozen
5.4.1. Frozen market estimates and forecasts 2021 - 2033 (USD Million)
5.4.2. Ultra-frozen/Deep-Frozen
5.4.2.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2021 - 2033 (USD Million)
5.4.3. Cryogenic
5.4.3.1. Cryogenic market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4. Europe
6.4.1. Europe Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.2. Germany
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Germany Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.3. UK
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. UK Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. South Korea Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Australia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Thailand Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7. MEA
6.7.1. MEA Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.6. Oman
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Oman Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
6.7.7. Qatar
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Qatar Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis, 2024
7.3. Company Profiles
7.3.1. Cardinal Health
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. DHL Group
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Agility
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. SF Express
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Kinesis Medical B.V.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. United Parcel Service of America, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Barrett Distribution
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Cencora
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. DB Schenker
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. FedEx
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Service benchmarking
7.3.10.4. Strategic initiatives
7.3.11. KUEHNE + NAGEL
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Service benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Kerry Logistics Network Ltd
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Service benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Freight Logistics Solutions
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Service benchmarking
7.3.13.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us